Fig. 5From: CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)Anchorage dependent and independent growth with CD44 or RHAMM loss in bladder cancer cells +/− AGL. a–d 72 h after UMUC3 or T24T shCTL and shAGL were transfected with siCTL, siCD44 or siRHAMM, they were plated for monolayer growth (n = 6) in 96-welled plate (103 cells/well) for 5 days followed by CyQUANT assay. e, f 72 h after UMUC3 or T24T shCTL and shAGL were transfected with siRNA against CD44 (siCD44) or RHAMM (siRHAMM) they were plated in agar for evaluation of anchorage independent growth (15x103 cells/well) in 6 well plate (n = 3). Results are shown as mean ± SD, *P < 0.05Back to article page